PRESS RELEASE published on 09/25/2023 at 07:06, 2 years 7 months ago Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)
PRESS RELEASE published on 09/19/2023 at 07:00, 2 years 7 months ago Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
PRESS RELEASE published on 09/19/2023 at 07:00, 2 years 7 months ago Biophytis fait le point sur ses programmes d’accès précoce pour Sarconeos (BIO101) dans le traitement des formes sévères de COVID-19
PRESS RELEASE published on 09/14/2023 at 07:00, 2 years 7 months ago Biophytis renforce sa direction avec la nomination de son Chief Business Officer
PRESS RELEASE published on 09/14/2023 at 07:00, 2 years 7 months ago Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
PRESS RELEASE published on 09/11/2023 at 07:00, 2 years 7 months ago Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 09/11/2023 at 07:00, 2 years 7 months ago Biophytis obtient l’autorisation de la FDA pour démarrer l’étude SARA-31 de phase 3 dans la sarcopénie
PRESS RELEASE published on 09/04/2023 at 23:00, 2 years 8 months ago Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York
PRESS RELEASE published on 09/04/2023 at 23:00, 2 years 8 months ago Biophytis participera à la 25ème Global Investment Conference de H.C. Wainwright à New York
PRESS RELEASE published on 08/16/2023 at 07:00, 2 years 8 months ago Biophytis announces next regulatory steps in Europe and the United States for its COVA project
Published on 05/08/2026 at 15:55, 4 hours 12 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 5 hours 7 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 5 hours 12 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 5 hours 37 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 6 hours 7 minutes ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 19:12, 54 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 hour 5 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 1 hour ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 1 hour ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 1 hour ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
